搜尋結果
Sage Therapeutics scraps plans for Parkinson's drug after mid-stage failure
Reuters· 3 日前, opens new tab said on Wednesday it would stop working on its experimental drug for Parkinson's disease after the treatment ...
How A Handful Of Drugs Is Squeezing Medicare
Forbes· 2 日前Medicare expects it will spend more $550 million this year for the controversial ...
mild cognitive impairment 相關
廣告